Kinex Pharmaceuticals
Biotechnology ResearchNew York, United States2-10 Employees
Kinex Pharmaceuticals was renamed to Athenex in 2015. Please go to the Athenex LinkedIn page at https://www.linkedin.com/company/10272783/.
Niche Market Focus Kinex Pharmaceuticals operates within the biotechnology research sector with a specialized focus, presenting an opportunity to tailor outreach efforts towards organizations seeking innovative biotech solutions and partnerships.
Startup Potential With a small team of 2-10 employees and recent funding of 60 million dollars, the company is positioned for growth, making it an ideal prospect for solutions that support expansion, R&D, and operational scaling.
Revenue Growth Opportunities Although revenue remains in the $1 million to $10 million range, the company's recent funding indicates potential for increased sales of high-value products or services aimed at enhancing research capabilities.
Strategic Value Proposition Being now part of Athenex, a larger entity, presents an opportunity to offer integrated biotech or pharmaceutical technology solutions that complement their innovation pipeline and strategic growth.
Competitive Differentiators Compared to industry giants, Kinex offers a more agile and innovative partner, making it appealing for collaborative projects, flexible licensing, or custom biotech research services aligned with cutting-edge trends.
| Kinex Pharmaceuticals Email Formats | Percentage |
| FLast@kinexpharma.com | 40% |
| Last@kinexpharma.com | 18% |
| Last_First@kinexpharma.com | 2% |
| FLast@kinexpharma.com | 40% |
Biotechnology ResearchNew York, United States2-10 Employees
Kinex Pharmaceuticals was renamed to Athenex in 2015. Please go to the Athenex LinkedIn page at https://www.linkedin.com/company/10272783/.
Kinex Pharmaceuticals has raised a total of $60M of funding over 9 rounds. Their latest funding round was raised on Dec 05, 2019 in the amount of $60M.
Kinex Pharmaceuticals's revenue is estimated to be in the range of $1M$10M
Kinex Pharmaceuticals has raised a total of $60M of funding over 9 rounds. Their latest funding round was raised on Dec 05, 2019 in the amount of $60M.
Kinex Pharmaceuticals's revenue is estimated to be in the range of $1M$10M